These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 6375610)

  • 1. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase.
    Weintraub M; Sundaresan PR; Schuster B; Averbuch M; Stein EC; Cox C; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):608-14. PubMed ID: 1587075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine.
    Weintraub M; Sundaresan PR; Schuster B; Moscucci M; Stein EC
    Clin Pharmacol Ther; 1992 May; 51(5):602-7. PubMed ID: 1587074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.
    Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD
    Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fenfluramine/phentermine combination for weight loss.
    Garrett SD; Cupp MJ
    Nurse Pract; 1997 Aug; 22(8):166, 168, 170. PubMed ID: 9279853
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
    Halladay AK; Fisher H; Wagner GC
    Neurotoxicology; 1998 Apr; 19(2):177-83. PubMed ID: 9553954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term drug treatment of obesity in a private practice setting.
    Atkinson RL; Blank RC; Schumacher D; Dhurandhar NV; Ritch DL
    Obes Res; 1997 Nov; 5(6):578-86. PubMed ID: 9449143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.
    Weintraub M; Sundaresan PR; Madan M; Schuster B; Balder A; Lasagna L; Cox C
    Clin Pharmacol Ther; 1992 May; 51(5):586-94. PubMed ID: 1587072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.
    Weintraub M; Sundaresan PR; Schuster B; Ginsberg G; Madan M; Balder A; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):595-601. PubMed ID: 1587073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
    Khan M; Lum CT; Rao V
    Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.
    Langlois KJ; Forbes JA; Bell GW; Grant GF
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):289-96. PubMed ID: 4208343
    [No Abstract]   [Full Text] [Related]  

  • 12. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine.
    Jones KL; Johnson KA; Dick LM; Felix RJ; Kao KK; Chambers CD
    Teratology; 2002 Mar; 65(3):125-30. PubMed ID: 11877776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesity.
    Rothman RB
    J Clin Psychiatry; 1996 Feb; 57(2):92-3. PubMed ID: 8591979
    [No Abstract]   [Full Text] [Related]  

  • 15. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of obesity with "combination" pharmacotherapy.
    Rothman RB
    Am J Ther; 2010; 17(6):596-603. PubMed ID: 19352140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine (Prozac) and other drugs for treatment of obesity.
    Med Lett Drugs Ther; 1994 Nov; 36(936):107-8. PubMed ID: 7968782
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between health-related quality of life and weight loss.
    Kolotkin RL; Crosby RD; Williams GR; Hartley GG; Nicol S
    Obes Res; 2001 Sep; 9(9):564-71. PubMed ID: 11557837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.